NPY Y5 antagonist
US7781461B2 · kind B2 · utility
4Cited by
14References
4Claims
0Family size
Inventors
Key dates
| Filing date | Sep 14, 2006 |
| Grant date | Aug 24, 2010 |
| Priority date | — |
| Expiry date | Jun 10, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.